On March 28, 2017, the National Academies of Sciences, Engineering, and Medicine released its phase two report by the Committee on A National Strategy for the Elimination of Hepatitis B and C. The report confirms that the elimination of hepatitis B and C as a public health concern in the United States is feasible by 2030 and recommends specific strategies, many of which align with the Centers for Disease Control and Prevention’s (CDC’s) priorities for viral hepatitis prevention, including:

• Decrease deaths by improving testing and access to treatment for people living with hepatitis B and hepatitis C.
• Reduce spread of hepatitis B and hepatitis C associated with drug use and other common routes.
• Prevent perinatal transmission (from mother to child) of hepatitis B and hepatitis C.
• Accelerate progress through prevention research, technical assistance, and partner engagement.

View the full report, the executive summary, and the recommendations. To explore the report and its implications more in-depth, interested parties are encouraged to save the date for an April 10 featuring Dr. Brian Strom, Chair of the National Academies panel that developed the report and recommendations, and/or plan to virtually join the 2017 Viral Hepatitis Summit.